MGMT and glioma: It is now also being realized that promoter methylation is not the only factor driving MGMT expression, but MGMT genomic rearrangements also have a fair share in determining MGMT expression with the evidence of such MGMT genomic rearrangements in recurrent gliomas leading to MGMT overexpression [30].